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The effects of 4P-phorbol 12-myristate 13-acetate (PMA), bombesin and insulin on 6- 
phosphofructo-2-kinase (PFK-2) activity, on fructose 2,6-bisphosphate concentration and on the 
phosphorylation state of PFK-2 were investigated in primary cultures of hepatocytes from foetal and 
adult rats. Bombesin stimulated PFK-2 activity and increased hexose phosphate (glucose &phosphate 
and fructose &phosphate) and fructose 2,6-bisphosphate content in hepatocytes both in the foetal 
and adult state. However, PMA-treated foetal cells exhibited a marked stimulation in fructose 2,6- 
bisphosphate concentration and in PFK-2 activity as well as in the content of hexose phosphates, 
while no response was found in the case of adult hepatocytes. Moreover, the effect of PMA on foetal 
hepatocytes was suppressed when cells were incubated with cycloheximide, but not when this effect 
was elicited by bombesin or insulin. These results, and those obtained on the phosphorylation state 
of PFK-2, suggest that there are different pathways that modulate fructose 2,6-bisphosphate content 
and, therefore, the control mechanisms of glycolysis and gluconeogenesis at this regulatory step, both 
in adult and foetal rat liver. 
The major changes observed in the transition from the 
foetal to the neonatal states are mainly due to nutritional and 
hormonal variations. At birth, the transplacental diet, rich in 
carbohydrates, is replaced by the high-fat diet of the suckling 
period. Late in the prenatal state, a series of metabolic modifi- 
cations in the liver may contribute to the development of the 
physiological adaptation of this organ for the newborn state. 
Marked changes concerning carbohydrate metabolism occur 
during the perinatal period which are controlled by hormones, 
among them a substantial decrease in hepatic glycolysis and 
in the insulin/glucagon ratio [I, 21 with an increased rate of 
gluconeogenesis [3]. 
Fructose 2,6-bisphosphate [Fru(2,6)P2] is known to play 
a major role in the control of glycolysis, through 6- 
phosphofructo-I -kinase, and gluconeogenesis, through fruc- 
tose-1.6-bisphosphatase [4]. It  has recently been reported that 
foetal hepatocytes contain a form of 6-phosphofructo-2- 
kinase (PFK-2), which shows no response to the glucagon- 
dependent inactivation exhibited by the adult hepatocytes [S]. 
However, in primary cultures of foetal hepatocytes (22-days 
old), the glucagon-induced inhibition of PFK-2 required at  
least 45 min to reach the half-maximal effect, suggesting that 
the adult form of this enzyme is rapidly induced after birth, 
probably due to the hormonal changes displayed during the 
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perinatal transition [6]. As foetal and adult hepatocytes con- 
tain different isoenzymes of PFK-2, we investigated the possi- 
bility that agonists, acting through the stimulation of protein 
kinase C and calcium mobilization, affect the activity of PFK- 
2 in primary cultures of foetal and adult hepatocytes. Evidence 
is presented that phorbol-ester-induced activation of protein 
kinase C, increased Fru(2,6)P2 concentration and PFK-2 ac- 
tivity in foetal hepatocytes. However, the adult hepatocytes 
lacked this effect. 
MATERIAL AND METHODS 
Animals 
Pregnant albino Wistar rats (300-350 g), fed on a stan- 
dard laboratory diet (Sanders H-28) with food and water ad 
lihitunz, were maintained at a constant day/night rhythm and 
controlled temperature (21 ‘ C). Gestational state was deter- 
mined by standard criteria [7]. On day 22 of gestation, rats 
were decapitated and foetuses were obtained. The livers from 
the foetuses were used immediately. Male albino Wistar rats 
(1  80 - 200 g), fed and maintained under the same conditions 
as above, were also used in order to compare foetal with adult 
hepatocytes. 
Materials 
Substrates, antibiotics, hormones, coenzymes and enzymes 
were obtained from Boehringer (Mannheim, FRG) or Sigma 
(St. Louis, MO, USA). Standard analytical-grade laboratory 
reagents were obtained from Merck (Darmstadt, FRG). Tis- 
sue-culture dishes were from Costar (Cambridge, MA, USA). 
Foetal-calf serum was from Biochrom (Berlin, FRG). Media 
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were from Gibco (Hounslow, England). Radiochemicals 
were purchased from Amersham International (Amersham, 
Buckinghamshire, England). 
Isolation of hepatocytes 
Isolated hepatocytes from 22-day-old foetal livers were 
obtained by a non-perfusion collagenase-dispersion technique 
as described previously [5]. Isolation of adult hepatocytes was 
carried out from 3-month-old rats by the classic collagenase- 
perfusion method [8]. 
Culture conditions and preparation of cell extracts 
Foetal and adult hepatocytes (1 O6 cells) were placed in 1.5- 
cm-deep tissue-culture dishes previously coated with collagen 
[6], which contained 1 ml Dulbecco’s modified Eagle’s me- 
dium (DMEM) supplemented with 2% (by vol.) foetal calf 
serum. The dishes were incubated at 37°C for 2 h in air with 
5% COz to facilitate the attachment of the cells. At the end 
of the 2-h period the medium was aspirated together with the 
unattached cells, the plates washed with 1 ml DMEM, the 
medium replaced by 1 ml DMEM containing 0.2% (by vol.) 
fatty-acid-free bovine serum albumin and incubated for 4 h. 
In experiments with [32P]phosphate-labelled cells, hepatocytes 
were cultured in 6-cm-wide dishes. After 2 h, the medium was 
replaced by DMEM containing 0.2% (by vol.) bovine serum 
albumin and 150 pCi/ml [3zP]phosphate. The incubation was 
maintained for 2 h to equilibrate the radiolabelling of the 
adenine nucleotide pool with [32P]phosphate. 4p-phorbol 12- 
myristate 13-acetate (PMA), bombesin and insulin were added 
to the dishes so that the total volume of the medium was not 
changed by more than 2%. PMA was prepared (1 mg/ml) in 
dimethyl sulfoxide. 
Bonibcsin and insulin were dissolved in sterile water in the 
appropriate concentration and were passed through a sterile 
0.22-pm-pore filter. In the experiments using cycloheximide, 
cells were incubated with it for 15 min before the addition of 
ligands. At the indicated times the medium was aspirated and 
the cell layer was used for the measurement of metabolites 
and enzymes. 
The specific radioactivity ofthe [.y3’P]ATP pool was deter- 
mined as follows: Samples of cell incubations were de- 
proteinized in 200 p10.5 M perchloric acid and sonicated (four 
pulses of30 s at 22 kHz). After centrifugation in an Eppendorf 
centrifuge the supernatants were neutralized with 0.5 M 
K2C03  and processed according to Garrison [9]. ATP was 
purified by HPLC with a Supelcosil-LC-SAX column 
(Sulpeco) at a flow rate of 1 ml/min, using an isocratic gradient 
of 0.4 M NaH2PO4, pH 4.5, and the absorbance at  260 nm 
was continuously recordcd. Appropriate internal standards of 
ATP were used to quantify the amount of ATP in the samples. 
The specific activity of [Y-~~PIATP was determined after trans- 
ference of‘ the ;! phosphate of the purified ATP to glucose 
in the presence of hexokinase, and the measurement of the 
radioactivity incorporated into glucose 6-phosphate (Glc6P) 
To mcasure the concentration of Fru(2,6)Pz, the attached 
cells were extracted with 0.4 ml50 mM NaOH and maintained 
for 10 min in a water bath at  80 ’C. For the measurement 
of enzyme activities, PFK-2 and fructose-2,6-bisphosphatase 
[Fru(2.6)P2ase], the cells were washed once with the DMEM 
without serum or  albumin and scraped off the dishes in 1 ml 
ice-cold buffer containing 100 mM NaF, 1 mM EDTA, 1 mM 
dithiothreitol and 20 mM KH2P04 ,  pH 7.4, and homogenized 
[91. 
by sonication (four periods of 20 s) at  maximal intensity. The 
suspensions were centrifuged at 105000 g for 30 min and the 
supernatants were then fractionated after precipitation with 
15% poly(ethy1ene glycol) [6]. After resuspension of the pellets 
in the extraction medium, PFK-2 activity was measured at 
pH 6.6 [in the presence of 5 m M  Mg . ATP and 1 mM fructose 
6-phosphate (Fru6P)I and at  pH 8.5 (5 mM Mg . ATP and 
5 mM FrubP). Fru6P was in a 1 : 3 ratio with Glc6P to prevent 
changes in its concentration. Fru(2,6)P2ase activity was deter- 
mined in the same fraction. 
To determine the phosphorylation state of PFK-2, 
hepatocytes were incubated in the presence of [32P]phosphate 
as described above, except that the poly(ethy1ene glycol) pellet 
was resuspended in 500 p1 200 mM NaCI, 1 mM dithio- 
threitol, 30 mM NaF, 1 mM MgCI’, 1 mM potassium phos- 
phate, 50 pM Fru6P and 20 mM Hepes, pH 7.4 (medium 
A), then mixed thoroughly with 1 ml medium A containing 
100 mg wet blue-Sepharose. The blue-Sepharose gel was 
washed 5 - 10 times, in batches, with 3 ml medium A contain- 
ing 0.8 M NaC1, until no radioactivity emerged. Under these 
conditions, at  least 85% of PFK-2 activity was retained by 
the gel. This recovery was not affected by thc hormonal treat- 
ment of the hepatocytes and therefore the phosphorylation 
state of the enzyme had no influence on its binding to the 
blue-Sepharose gel. PFK-2 activity was extracted from the gel 
after heating at  80°C for 5 min with 250 p1 Laemmli’s sample 
buffer followed by SDSjPAGE (loo/, gel) and stained with 
Coomassie brilliant blue [lo], dried and exposed to X-ray film. 
Gels were loaded with amounts of protein corresponding to 
the poly(ethy1ene glycol) fractions. The protein content at this 
step was approximately 200 pg. Alternatively, the proteins 
from the gels were transferred to nitrocellulose membranes 
(0.5 mA/cm2; 15 h) and submitted to Western-blot analysis 
using a polyclonal antibody recognizing both foetal and adult 
PFK-2. In the latter case, the stained blots were excised and the 
radioactivity corresponding to the PFK-2 band was measured. 
Preparation of anti-PFK serum 
Adult liver PFK-2 was purified according to Rider et al. 
[l I]. Antibodies were prepared by multiple intradermal injec- 
tions of an  emulsion of 0.5 mg purified enzyme in 0.5 ml 
Freund’s complete adjuvant into male New Zealand rabbits, 
followed by 0.2-mg booster injections of enzyme/adjuvant 
every two weeks. Blood was collected and the serum was 
separated and stored at - 70 ’C. This antibody failed to com- 
pletely precipitate PFK-2, either from foetal or adult 
hepatocytes, but recognized both enzymes in Western-blot 
analysis. 
Measurements of metabolites and enzyme activities 
Fru(2,6)Pz was measured by the method of Van 
Schaftingen et al. [I 21. Glc6P and Fru6P concentrations were 
determined enzymically as previously described [I 31. Protein 
concentration was determined by the method of Bradford [14] 
with bovine serum albumin as standard. PFK-2 activity was 
assayed as described by Martin-Sanz et al. (61. 1 U of PFK-2 
activity is the amount of enzyme that catalyzes the formation 
of 1 pmol Fru(2,6)P2/min. Fru(2,6)P2ase activity was assayed 
following the method of Van Schaftingen et al. [l 51 in which 
the release of [32P]phosphate from [2-32P]Fru(2,6)Pz was mea- 
sured. [2-32P]Fru(2,6)P2 was prepared as described by Rider 
et al. [ l l] .  1 U of Fru(2,6)P2ase activity is the amount of 
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Fig. 1. Time course of Fru(2,6)PZ formation in cultures of foetal (A) 
andadult(6) hepatocytes. ( 0 ) P M A .  160 nM; (m) bombesin, 100 nM;  
(A) insulin, 100 nM ; (0) control. Cells were incubated in the medium 
(DMEM) supplemented with 0.2% fatty-acid-free bovine serum albu- 
min) for 2 h.  The medium was replaced, and cells were incubated in 
thc presencc of the indicated substances for 1 -4 h. Results are means 
& SEM from four different experiments. *, P < 0.001 
enzyme that catalyzes the release of 1 pmol [32P]phosphate/ 
min. 
Protein-kinase-C activity was measured after homogeniza- 
tion of Ihe cells in 2 ml 0.25 M sucrose, 10 mM 2-mer- 
captoethanol, 1 mM EGTA, 1 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride, 20 pg leupeptin and 20 mM 
Hepes, pH 7.4. The homogenate was centrifuged at  105000 g 
for 30 min and the soluble and particulate fractions were 
purified by DEAE-cellulose (DE52) chromatography [16]. 
The particulate activity was extracted with homogenization 
buffer supplemented with 0.15% Nonidet P40. The activity of 
protein kinase C was followed by phosphorylation of histone 
H1 in the absence or presence of C a 2 + ,  phosphatidylserine 
and diacylglycerol as previously described [ 161. 
RESULTS 
Fru(2,6)P2 in foetal and adult hepatocytes 
To investigate whether the induced activation of inositol 
phospholipids turnover, or the direct activation of PKC affects 
the activity of PFK-2 and the concentration of Fru(2,6)P2, 
foetal and adult hepatocytes were incubated with PMA, 
bombesin and insulin. Fig. 1 shows the effect of PMA, 
bombesin and insulin on the concentration of Fru(2,6)P2 in 
foetal and adult hepatocytes incubated in parallel at 37 ’C for 
up to 4 h. In foctal hepatocytes, Fru(2,6)P2 showed a marked 
and progressive increase, due to the effect of these substances, 
during the first 4 h of incubation. The increased Fru(2,6)P2 
content was maintained for up to 24 h. However, in 
hepatocytes from adult rats, PMA failed to show any effect 
on Fru(2,6)P2 content. The activation of protein kinase C 
after exposure of hepatocytes to PMA was assessed after 
determination of the subcellular distribution of this enzyme, 
both in adult and foetal cells, since the activating effect of 
PMA on protein kinase C involves the translocation of this 
enzyme from the cytosol to the membranes [17]. As shown in 
Table 1. at least 80% of the total activity was found in the 
membranes 2 min after exposure to phorbol esters. 
The increase in the concentration of Fru(2,6)P2 in cultured 
foetal hepatocytes in response to PMA, bombesin and insulin 
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Table 1. Suhcellular distribution of protein kinase C in PMA-exposed 
hepatocytes. Hepatocytes ( 5  x lo6 cells) were incubated with 160 nM 
PMA, homogenized and centrifuged at  105000 g to yield soluble and 
particulate fractions. After extraction from thc membranes and partial 
purification by DEAE-cellulose chromatography, protein kinase C 
(PKC) was measured. Total protein-kinase-C activity corresponds to 
the addition of the activity present in each compartment. Results are 
means of two indcpendent cell preparations. 
Hepatocytes Time Fraction PKC activity Total PKC 
activity 
soluble particulate 
min % mU/mg protcin 
Adult 0 57 43 7.1 
2 12 88 6.8 
30 5 9s 2.1 
Foctal 0 75 25 10.5 
2 21 79 9.4 
30 I 93 5.3 
was time dependent and required at  least 4 h to reach a 
maximum (Fig. 1 A). The changes observed in Fru(2,6)P2 con- 
centration after exposure of foetal or adult hepatocytes to 
these ligands (bombesin, insulin and PMA in the case of 
foetal hepatocytes), followed nearly identical time courses. 
Moreover, the time required to obtain the half-maximal ex- 
pression of this effect was also similar (1.5 h). In contrast, 
adult hepatocytes incubated in the presence of PMA failed to 
show changes in their content of Fru(2,6)P2 but surprisingly, 
as in the foetal state, bombesin retained its ability to promote 
a rise in the level of this metabolite (Fig. 1 B). This is despite 
the fact that both PMA and bombesin promote the activation 
of protein kinase C either directly, as in the case of PMA [17, 
181 (Table 1) or indirectly through the metabolites derived 
from inositol phospholipids turnover (bombesin) [19]. Insulin 
produced the already described increase in Fru(2,6)P2 [20,21]. 
Table 2 shows the concentrations of Fru(2,6)P2 in foetal 
and adult hepatocytes incubated for 4 h under the different 
experimental conditions, as well as when bombesin or insulin 
were incubated with PMA. No apparent synergism between 
these ligands was observed in cells from either foetal or adult 
rats. 
To test whether the effects of PMA, bombesin and insulin 
depend on protein synthesis, primary cultures of foetal and 
adult hepatocytes were incubated for 15 min with 1 pM 
cycloheximide before the addition, at  saturating concen- 
trations, of the ligands (160 nM PMA; 100 nM bombesin; 
100 nM insulin). The incubation was followed for 4 h and 
samples were collected to determine Fru(2,6)P2 concentration 
(Table 2) and PFK-2 activity (Table 3) .  Cycloheximide slightly 
decreased the Fru(2,6)P2 content in control cells (from 100% 
to 910/) and suppressed the increase in Fru(2,6)P2 concen- 
tration elicited by PMA in foetal hepatocytes. In contrast to 
this effect, exposure of both foetal and adult hepatocytes, 
previously treated with cycloheximide, to bombesin or insulin 
did not show any influence on the intracellular concentration 
of Fru(2,6)P2. The effects of cycloheximide on Fru(2,6)P2 
were parallel to changes in PFK-2 activity. 
Hexose phosphates 
The concentration of Fru(2,6)P2 may be modulated by the 
activity of PFK-2/Fru(2,6)P2ase and by the changes in the 
Table 2. Hexose phosphate and Fru(2,6)P, content in foetal and adult hepatocytes incubated in the presence of PMA, bombesin and insulin and 
the effects of cycloheximide. Primary cultures of hepatocytes from foetal and adult rats were incubated in the medium (DMEM supplemented 
with 0.2% fatty-acid-free bovine serum albumin) for 2 h. The medium was replaced and cells were incubated in the presence of the indicated 
substances for 4 h. Incubation with 1 pM cycloheximide was carried out for 15 min before the addition of PMA, insulin and bombesin. Results 
are means f SEM of four experiments. n.d., not determined. 
Hepatocyte Addi tion(s) 
type 
Glc6P/Fru6P content Fru(2,6)P2 content 
control cycloheximide 
Foetal none 
160 nM PMA 
100 nM bombesin 
100 nM bombesin/l60 nM PMA 
100 nM insulin 
100 nM insulin/l60 nM PMA 
Adult none 
160 nM PMA 
100 nM bombcsin 
100 nM bombesin/l60 nM PMA 
100 nM insulin 
100 nM insulin/l60 nM PMA 
pmol/mg protein 
~~ 
48, 1 
7 0 5  6' 
62f  7 
79* 5 
62f  5' 
161 f 18" 
n.d. 
128f 8 b  
n.d. 
19* 2h 
n.d. 
n.d. 
1 1 f 1  
39 f 3" 
36 + 3" 
36 f 3" 
34 f 3" 
31 f 2" 
1 8 f 2  
20 f 2 
40 f 5" 
42 f 4" 
34 f 4" 
40 f 5" 
1 0 5  1 
15 f 2" 
30 f 3 
n.d. 
30 t 3 
n.d. 
1 8 f 2  
1 1 f 2  
36 f 4 
n.d. 
29 f 2 
n.d. 
~ ~~~ ~ 
Significant difference from control (none), P < 0.001. 
Significant difference from control (none), P < 0.01, 
Significant difference from control (none), P < 0.05. 
Table 3. PFK-2 and Fru(2,6)P2 in foetal and adult hepatocytes incubated in the presence of PMA, bombesin and insulin with effects of cycloheximide. 
Primary cultures of hepatocytes from foetal and adult rats were incubated in the medium (DMEM supplemented with 0.2% fatty-acid-free 
bovine scrum albumin) for 2 h. The medium was eliminated and replaced and cells were incubated in the presence of the indicated substances 
for 4 h.  Incubation with 1 pM cycloheximide was carried out for 15 min before the addition of PMA, bornbesin or insulin. PFK-2 total activity 
was measured at pH 8.5. Results are means f SEM of four experiments. n.d., not determined. 
~ 
H cpa t ocyt c 
type 
Addition 
~ ~~ ~~ ~ ~ ~ 
PFK-2 activity Fru(2,6)P2ase PFK-2 
- activity Fru(2,6)P2ase 
control cycloheximide activity 
mU/g protein 
Foetal none 
160 nM PMA 
100 nM bombesin 
100 nM bombesin/l60 nM PMA 
100 nM insulin 
100 nM insulin/lhO nM PMA 
Adult none 
160 nM PMA 
100 nM bombesin 
100 nM bombesin/l60 nM PMA 
100 nM insulin 
100 nM insulin/l60 nM PMA 
24 f 3 22 * 3 
41 f 3 '  16 & 2h 
3 7 f 2 b  3 2 f 4  
45 f 3" n.d. 
29 f 3 28 f 3 
37 f 4" n.d. 
3 8 f 4  3 5 f 4  
3 6 f 2  31 + 3  
51 f 5  40 f 5 
60 f 3' n.d. 
52 f 4' 47 f 6 
56 f 6' n.d. 
0.17 f 0.01 
0.19 f 0.02 
0.27 f 0.02" 
n.d. 
n.d. 
n.d. 
18 f 2  
9 f 2 "  
11 f 2  
n.d. 
n.d. 
n.d. 
141 f l 0  
215 +20" 
137 f 10 
n.d. 
n.d. 
n.d. 
2.1 f 0.2 
4.0 f 0.3" 
4.6 f 0.4" 
n.d. 
n.d. 
n.d. 
Significant difference from control (none), P < 0.001 
Significant difference from control (none), P < 0.01. 
Significant difference from control (none), P < 0.05. 
concentration of Fru6P. For this reason, hexose-phosphate 
(Glc6P and Fru6P) concentration was also determined. The 
results obtained are shown in Table 2. Hexose-phosphate con- 
tent increases in foetal hepatocytes incubated in the presence 
of PMA (165%, P < O.Ol), bombesin (146%, P < 0.05) and 
insulin (129%), which provides a mechanism to explain the 
effect of insulin on the Fru(2,6)P2 concentration. However, in 
adult hepatocytes, the hexose-phosphate concentration de- 
creases in response to PMA (78%) and increases in the presence 
of bornbesin (204%, P < 0.001) and insulin (162%, P < 0.01). 
The differing behaviours of foetal and adult hepatocytes with 
PMA agrees with the previously described results. 
PFK-2 and Fru(2,6)P,ase activities 
The maximal activity of PFK-2 was measured in primary 
cultures of foetal and adult hepatocytes incubated for 4 h in 
the presence of PMA, bombesin and insulin. This sampling 
time was chosen because of the important changes that occur 
during this period [6]. As shown in Table 3 ,  an increase in the 
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Fig. 2. In vivo phosphorylation of PFK-2. Hepatocytes ( 5  x 10' cells) 
were incubated with [32P]phosphate for 2 h prior to the addition of 
100 nM glucagon, 160 nM PMA, 100 nM bombesin, or 100 nM insu- 
lin (lanes 2 - 5 ,  rcspcctively). Cells were exposed for 10 min to these 
hormones and growth factors and processed in parallel. Cell 
honiogcnates were fractionated by poly(ethy1ene glycol) and blue- 
Sepharosc chromatography (lane 1 ,  control). Foetal hepatocytes; (B) 
adult hepatocytes. Specific radioactivities of [y-32P]ATP (pCi/nmol): 
0.37, 0.39, 0.35, 0.33, 0.34 (A, lanes 1 -S), 0.12, 0.14, 0.17, 0.16 and 
0.17 ( R ,  lanes 1-5). 
activity of PFK-2 was evident in foetal hepatocytes when 
incubated in the presence of PMA (171%, P <  0.01) and 
bombesin (154%, P < 0.01). The increase observed by the 
effect of insulin (321%) was less evident. For PMA and 
boinbesin these results are in agreement with the changes in 
the concentration of Fru(2,6)P2. The same holds true for adult 
hepatocytes in which PMA did not produce changes in the 
concentration of Fru(2,6)Pz or in the activity of PFK-2. 
The Fru(2,6)P2ase activity was determined in foetal and 
in adult hepatocytes and the results obtained showed that in 
the foetal cells the effect of bombesin produced a significant 
increase while no changes were seen with PMA. However, 
this enzyme activity was less than the control when adult 
hepatocytes were incubated in the presence of PMA or 
bombesin (Table 3). This suggests the occurrence of a 
Fru(2,6)P2ase activity in foetal hepatocytes, different from 
the PFK-2/Fru(2,6)P2ase bifunctional enzyme. 
The activity ratio PFK-2/Fru(2,6)P2ase was 70-fold higher 
in foetal than in adult hepatocytes (Table 3), due to the low 
Fru(2,6)Pzase activity in foetal cells. Exposure of foetal 
hepatocytes to PMA produced an increase (1 52%) in this ratio 
through a rise in the PFK-2 activity, whereas in adult cells 
the increase in this ratio was mediated through a decreased 
Fru(2,6)P2ase activity. These data agree with previous results 
concerning the low activity of Fru(2,6)Pzase in foetal liver [5] 
and in hepatoma cells [22]. 
In vivo phosphorylation of PFK-2 
To determine the phosphorylation state of PFK-2, primary 
cultures of foetal and adult hepatocytes were radiolabelled 
with [32P]phosphate, and the specific activity of [y-32P]ATP 
was determined at sampling times (10 min and 4 h after ligand 
addition), as described in Materials and Methods. PMA, 
boinbesin and insulin, as well as glucagon (as a positive control 
of adult PFK-2 phosphorylation), were added to [32P]phos- 
phate-labelled cells, prepared as described above. Samples 
were collected to determine the extent of PFK-2 phosphoryla- 
tion and the specific activity of ATP. The cell extracts were 
fractionated by poly(ethy1ene glycol) and absorbed onto blue- 
Sepharose to decrease the background of phosphoproteins. 
By using this procedure only, 5 - 15% of PFK-2 activity was 
detected in the supernatants. In foetal hepatocytes, 10 min of 
incubation with glucagon produced a marked increase in the 
phosphorylation state of a 54-kDa protein and a lesser phos- 
phorykation of two proteins of 60 kDa and 52 kDa (Fig. 2) .  
When foetal hepatocytes were stimulated with PMA or 
bombesin, the same proteins were phosphorylated, although 
the incorporated phosphate was less than after incubation 
with glucagon. Insulin failed to show changes in the phos- 
phorylation of proteins purified with blue-Sepharose. When 
the same experiment was carried out with adult hepatocytes, 
only glucagon produced a clear phosphorylation of a protein 
of 54 kDa [5, 61. The specific activity of [Y-~~P]ATP was 
0.36 f 0.03 pCi/nmol ATP and 0.15 A 0.03 pCi/nmol ATP for 
foetal and adult hepatocytes, respectively. The corresponding 
values for each condition are given in the legend to Fig. 2. 
To identify the band corresponding to PFK-2 in foetal 
hepatocytes, samples were processed by SDSjPAGE followed 
by Western-blot analysis using a polyclonal rabbit anti-(rat 
liver PFK) serum that recognized both the foetal and adult 
enzymes. Only the band corresponding to 54 kDa was stained. 
This is an additional proof that the radioactivity measured 
for the 54-kDa protein, effectively corresponds to PFK-2. In 
samples obtained after 4 h of incubation with the hormones, 
the protein bands recognized by Western-blot analysis were 
excised and the radioactivity associated with the stained bands 
(Table 4) shown to exhibit a pattern similar to those given in 
Fig. 2. The specific activity of [Y-~~P]ATP for each incubation 
is shown in Table 4. 
PFK-2 activity, expressed as activity at pH 8.5/activity at 
pH 6.6, was determined in the poly(ethy1ene glycol) extracts, 
since in adult liver, the activity at pH 8.5 represents the total 
activity of PFK-2 independently of the phosphorylation state 
of the enzyme, and at pH 6.6, the activity of PFK-2 decreases 
when the enzyme is phosphorylated [23]. In foetal hepatocytes, 
no significant changes were observed in this activity ratio of 
PFK-2 regardless of the phosphorylation state of the enzyme. 
In adult hepatocytes only glucagon increased the activity ratio 
(Table 4). Since phosphorylation of PFK-2 from foetal 
hepatocytes is observed after 10 min of exposure to PMA or 
bombesin, it is concluded that phosphorylation itself is not 
involved either in the changes in Fru(2,6)P2 concentration 
(Fig. 1) or in the kinetic variations observed in PFK-2 (Ta- 
ble 3) .  
Hepatocytes from foetal and adult rats were incubated for 
4 h  in the presence of increasing concentrations of PMA, 
bombesin and insulin and the content of Fru(2,6)P2 was deter- 
mined (Fig. 3 ) .  Fru(2,6)Pz production was similar in both 
foetal and adult hepatocytes exposed to bombesin (Fig. 3 R) 
or insulin (Fig. 3 C). However, the PMA-induced increase in 
Fru(2,6)P2, which reached a maximum in foetal hepatocytes 
at 40 nM PMA, remained unchanged when adult cells were 
incubated with increased concentrations of this ligand 
(Fig. 3A). 
DISCUSSION 
We studied the effect of PMA, bombesin and insulin on 
the PFK-2/Fru(2,6)P2ase system in primary cultures of foetal 
and adult hepatocytes for up to 8 h. The biological responses 
elicited by these substances, involving changes in the PFK-2/ 
Fru(2,6)P2ase activity and Fru(2,6)P2 concentration, required 
at least 4 h to be fully expressed and, therefore, the use of 
these primary cultures provides an efficient model for study. 
The present results suggest that growth factors and tumour 
promoters modulate Fru(2,6)P2 concentration in two ways; 
either by an increase in PFK-2 activity or by changes in the 
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Table 4. Phosphorylation of PFK-2 in hepatocytes incubated with PMA, insulin, bombesin or glucagon. Hepatocytes (5 x 10' cells) were 
radiolabelled with ["P]phosphate for 2 h prior lo the addition of the ligands. After 4 h, cells were homogenized and the cell extracts were 
fractionated by poly(ethy1ene glycol) and affinity chromatography on blue-Sepharose. The SDSjPAGE was followed by Western-blot analysis 
using anti-PFK-2 serum, and the stained bands were excised and the radioactivity detected. Radioactivities are means & SEM of three different 
experiments. The specific radioactivities of [y-32P]ATP are the means of two independent determinations and the ratio of PFK-2 activity 
measured at  pH 8.5 and pH 6.6 was carried out as described in Materials and Methods. 
Additions Foetal hepatocyte Adult hepatocyte 
radioactivity/ PFK-2 activity [Y-~*P]ATP radioactivity/ PFK-2 activity [1y32P]ATP 
band ratio specilic band ratio specilic 
activity activity 
~~ ____~.. -- 
Yo mCi/pmol Yo mCi/pmol 
None 102, 21 1.1 0.35 74+ 12 1.0 0.17 
100 nM glucagon 3122 k410" 1.0 0.38 1392 + 331 a 3.7 0.18 
100 nM bombesin 873 * 74" 1.0 0.37 8 4 k  17 1 .0 0.15 160 nM PM 544, 85 1.2 0.41 6 1 ,  12 0.9 0.38 
100 nM insulin 159+ 26 1.1 0.40 9 0 +  18 1.2 0.20 
Significantly different to control, P < 0.001, 
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Fig.3. Doselresponse curves of PMA (A), bombesin (B) and insulin (C) on Fru(2,6)PZ concentrations in foetal (0) and adult ( A )  hepatocytes. 
Cells were incubated in the medium (DMEM supplemented with 0.2% fatty-acid-free bovine serum albumin) for 2 h. The medium was replaced 
and cells were incubated for 4 h in the presence of several concentrations of agonists. Results arc means , SD of four replicates in a 
representative experiment. * P < 0.001. 
concentration of Fru6P, and these mechanisms may influence 
the glycolytic and gluconeogenic fluxes at  the level of Fru6P/ 
Fru( 1,6)P2 conversion [24]. The most notable differences be- 
tween the foetal and adult cells in the PFK-2/Fru(2,6)P2ase 
system were in the response following the activation of protein 
kinase C by phorbol esters. Adult hepatocytes lacked this 
response. However, foetal liver cells exhibited a marked en- 
hancement in Fru(2,6)P2, in hexose-phosphate content and in 
PFK-2 activity when exposed to PMA at concentrations in 
the range of maximal protein-kinase-C activation (160 nM). 
As protein kinase C is the biological receptor of phorbol esters, 
i t  is suggested that the effects of PMA are solely mediated by 
protein-kinase-C activation [17], which is in contrast to the 
activation of protein kinase C via an enhancement in the 
inositol phospholipid turnover where other messengers 
(diacylglycer3l and Ca2 + ) are increased. The results obtained 
after exposure of foetal hepatocytes to PMA are in agreement 
with those reported for the activation of other cell types, such 
as chick embryo fibroblasts [2S], human fibroblasts [26] and 
murine lymphocytes [13]. Moreover, in foetal cells the rise in 
the concentration of Fru(2,6)P2 and in PFK-2 activity may 
be related to an enhjnced rate of translation of PFK-2 mRNA, 
as suggested by the suppressive effect of cycloheximide; the 
stability of the protein seems not to be affected by PMA, since 
similar activities were observed in control and cycloheximide- 
treated cells. 
The mechanism by which protein-kinase-C activation in- 
creases PFK-2 activity is still not clear, although evidence has 
been provided showing a direct effect of protein kinase C on 
the phosphorylation state [27,28] that, according to Kitamura 
et al. produced a twofold increase in V,,, without affecting 
the affinity for Fru6P in PFK-2 from bovine heart [28]. In 
our studies, incubation of foetal hepatocytes with PMA and 
bombesin produced a clear in vivo phosphorylation of PFK- 
2, whereas this response was absent in adult hepatocytes. 
Glucagon, used as a control for the phosphorylation of the 
adult enzyme, also promoted the phosphorylation of PFK-2 
in foetal cells, suggesting that this enzyme is a substrate for 
both protein kinase C and cyclic-AMP-dependent protein 
kinase as described for the bovine heart enzyme [28]. However, 
PFK-2 from foetal hepatocytes, incubated with either PMA or 
glucagon did not exhibit changes in the activity ratio (pH S.S /  
pH 6.6; Table 4), nor in their affinity for Fru6P nor in their 
sensitivity to sn-glycerol 3-phosphate inhibition (data not 
shown). 
The bombesin-transduction pathway involves the acti- 
vation of a inositol-phospholipid-specific phospholipase C, 
producing an  increase in the diacylglycerol content in the 
plasma membrane and a rise in the free cytosolic calcium 
concentration [19]. These second messengers are activators of 
protein kinase C [17]. However, the involvement of protein 
kinase C in the bombesin-induced rise in the level of 
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Fru(2,6)P2 in adult hepatocytes seems unlikely, since direct 
activation of protein kinase C by PMA produced a lower 
response than that observed with bombesin and both failed 
to promote the phosphorylation of the enzyme. To explain 
the effect of bombesin in these cells, the Ca2 + mobilization 
elicited by this agonist should be considered because 
bombesin, acting like other Ca2+-mobilizing hormones, may 
stimulate glycogen degradation and therefore produce a sus- 
tained increase in the hexose-phosphate level that may explain 
its effects on the concentration of Fru(2,6)P2. Another possi- 
ble explanation for the bombesin-induced enhancement of 
PFK-2 activity is that the second messengers elicited by this 
growth factor may reinforce the stability of PFK-2. 
Insulin acting by mechanisms independent of Ca2' or 
protein-kinase-C stimulation, produced in adult hepatocytes 
changes in Fru(2,6)P2 content and in PFK-2 activity, similar 
to those obtained with bombesin. This is in agreement with a 
previous study on adult hepatocytes cultured for 48 h [20], 
although in that report, insulin only increased PFK-2 activity 
without affecting the concentration of Fru6P. However, PFK- 
2 was not phosphorylated in hepatocytes incubated with insu- 
lin. The rise in the level of hexose phosphate observed in our 
experiments may be explained by the use of shorter incubation 
times with hepatocytes which would contribute to the main- 
tenance of the hepatic phenotype. Concerning the mechanism 
by which insulin increases PFK-2 activity, it is suggested that 
the hormone helps to stabilize the enzyme, since in diabetic 
animals the decreased PFK-2 activity is largely due to a de- 
crease in the enzyme content but not in the mRNA for PFK-2/ 
Fru( 2,6)P2ase [29]. 
In contrast to the adult hepatocytes, in foetal cells the effect 
of insulin seems to be exclusively mediated by the increase in 
the concentration of hexose phosphate. However, in a pre- 
vious work with foetal hepatocytes [6], no changes were ob- 
served in Fru(2,6)P2 concentration in response to insulin, 
probably due to the use of different experimental conditions 
(DMEM instead of Leibowitz L-15 media and recombinant 
human insulin instead of the porcine hormone). Moreover, 
the results shown in Fig. 3 suggest that the effect of insulin 
may be due, in part, to binding to insulin-like-growth-factor 
receptors, in view of the concentration of insulin (100 nM) 
used in this study. The different regulation of PFK-2 in foetal 
or adult hepatocytes in response to insulin and glucagon [6], 
as well as the differential phosphorylation pattern observed 
iri vivo after activation of the cyclic-AMP-dependent protein 
kinase and protein kinase C, emphasises our proposal that 
there is a foetal form of PFK-2 with regulatory properties 
different from those found in the adult liver enzyme [ 5 ,  61. 
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